H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Neuroscience H-index 131 Citations 48,991 324 World Ranking 80 National Ranking 52

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Neuroscience
  • Internal medicine

Mark H. Tuszynski mainly focuses on Neuroscience, Spinal cord injury, Spinal cord, Neurotrophic factors and Nerve growth factor. His work carried out in the field of Neuroscience brings together such families of science as Growth factor, Neurotrophin and Regeneration. His Neurotrophin study combines topics from a wide range of disciplines, such as Stem cell and Transplantation.

His Spinal cord injury study incorporates themes from Clinical trial, Neurotrophin-3, Central nervous system, Nervous system and Spontaneous recovery. The various areas that Mark H. Tuszynski examines in his Spinal cord study include GDF7, Neuron, Anatomy and Neural stem cell. The concepts of his Nerve growth factor study are interwoven with issues in Lesion, Pathology, Genetic enhancement and Cholinergic.

His most cited work include:

  • A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease (850 citations)
  • A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease (850 citations)
  • Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury (711 citations)

What are the main themes of his work throughout his whole career to date?

Mark H. Tuszynski mostly deals with Neuroscience, Spinal cord injury, Spinal cord, Neurotrophic factors and Nerve growth factor. His study in Neuroscience is interdisciplinary in nature, drawing from both Neurotrophin and Regeneration. His Spinal cord injury research integrates issues from Lesion, Clinical trial, Pathology, Transplantation and Neural stem cell.

His studies deal with areas such as Neuron, Pyramidal tracts, Anatomy, Cell biology and GDF7 as well as Spinal cord. His Neurotrophic factors research includes elements of Growth factor and Disease. His biological study spans a wide range of topics, including Endocrinology, Genetic enhancement, Gene delivery and Cholinergic neuron.

He most often published in these fields:

  • Neuroscience (92.92%)
  • Spinal cord injury (67.92%)
  • Spinal cord (51.42%)

What were the highlights of his more recent work (between 2013-2020)?

  • Neuroscience (92.92%)
  • Spinal cord injury (67.92%)
  • Spinal cord (51.42%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Neuroscience, Spinal cord injury, Spinal cord, Neural stem cell and Regeneration. His Spinal cord injury research incorporates elements of Embryonic stem cell, Central nervous system, Anatomy, Primate and Lesion site. The concepts of his Spinal cord study are interwoven with issues in Lesion, Pathology, Inhibitory postsynaptic potential and Glial fibrillary acidic protein.

His work carried out in the field of Neural stem cell brings together such families of science as White matter, Progenitor cell, Progenitor, Axon and Transplantation. His Regeneration study deals with the bigger picture of Cell biology. His Cholinergic study incorporates themes from Cortex and Nerve growth factor.

Between 2013 and 2020, his most popular works were:

  • A shared neural ensemble links distinct contextual memories encoded close in time (420 citations)
  • A shared neural ensemble links distinct contextual memories encoded close in time (420 citations)
  • Long-Distance Axonal Growth from Human Induced Pluripotent Stem Cells after Spinal Cord Injury (209 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Neuron

Mark H. Tuszynski mainly investigates Neuroscience, Spinal cord injury, Neural stem cell, Spinal cord and Regeneration. Mark H. Tuszynski performs integrative study on Neuroscience and Context in his works. His research in Spinal cord injury intersects with topics in White matter, Embryonic stem cell and Central nervous system.

His study in Neural stem cell is interdisciplinary in nature, drawing from both Neurogenesis and Growth factor. Mark H. Tuszynski combines subjects such as Anatomy, Pathology, Primate, Induced pluripotent stem cell and Transplantation with his study of Spinal cord. His research in Regeneration tackles topics such as Axon which are related to areas like Regulation of gene expression, Peripheral nervous system, Systems biology and Neurite.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury

P Lu;L.L Jones;E.Y Snyder;M.H Tuszynski;M.H Tuszynski.
Experimental Neurology (2003)

1080 Citations

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

Alan H Nagahara;David A Merrill;Giovanni Coppola;Shingo Tsukada.
Nature Medicine (2009)

919 Citations

Cellular Delivery of Neurotrophin-3 Promotes Corticospinal Axonal Growth and Partial Functional Recovery after Spinal Cord Injury

R. Grill;K. Murai;A. Blesch;F. H. Gage.
The Journal of Neuroscience (1997)

781 Citations

Long-Distance Growth and Connectivity of Neural Stem Cells after Severe Spinal Cord Injury

Paul Lu;Yaozhi Wang;Lori Graham;Karla McHale.
Cell (2012)

679 Citations

The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury.

Leonard L Jones;Richard U Margolis;Mark H Tuszynski;Mark H Tuszynski.
Experimental Neurology (2003)

613 Citations

Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression

Michael B. Rosenberg;Theodore Friedmann;Robin C. Robertson;Mark Tuszynski.
Science (1988)

582 Citations

NG2 Is a Major Chondroitin Sulfate Proteoglycan Produced after Spinal Cord Injury and Is Expressed by Macrophages and Oligodendrocyte Progenitors

Leonard L. Jones;Yu Yamaguchi;William B. Stallcup;Mark H. Tuszynski;Mark H. Tuszynski.
The Journal of Neuroscience (2002)

574 Citations

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials

J W Fawcett;A Curt;J D Steeves;W P Coleman.
Spinal Cord (2007)

571 Citations

Combinatorial Therapy with Neurotrophins and cAMP Promotes Axonal Regeneration beyond Sites of Spinal Cord Injury

Paul Lu;Hong Yang;Leonard L. Jones;Marie T. Filbin.
The Journal of Neuroscience (2004)

465 Citations

Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures

J. D. Steeves;D. Lammertse;A. Curt;J. W. Fawcett.
Spinal Cord (2007)

426 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Mark H. Tuszynski

Fred H. Gage

Fred H. Gage

Salk Institute for Biological Studies

Publications: 80

Joost Verhaagen

Joost Verhaagen

Royal Netherlands Academy of Arts and Sciences

Publications: 63

Evan Y. Snyder

Evan Y. Snyder

Discovery Institute

Publications: 61

Hideyuki Okano

Hideyuki Okano

Keio University

Publications: 54

Molly S. Shoichet

Molly S. Shoichet

University of Toronto

Publications: 50

Jianwu Dai

Jianwu Dai

Chinese Academy of Sciences

Publications: 49

Wolfram Tetzlaff

Wolfram Tetzlaff

University of British Columbia

Publications: 48

Mary Bartlett Bunge

Mary Bartlett Bunge

University of Miami

Publications: 47

Jerry Silver

Jerry Silver

Case Western Reserve University

Publications: 46

Karim Fouad

Karim Fouad

University of Alberta

Publications: 45

Jeffrey H. Kordower

Jeffrey H. Kordower

Rush University Medical Center

Publications: 44

Melitta Schachner

Melitta Schachner

Rutgers, The State University of New Jersey

Publications: 44

Zhifeng Xiao

Zhifeng Xiao

Chinese Academy of Sciences

Publications: 39

Alan R. Harvey

Alan R. Harvey

University of Western Australia

Publications: 35

Elizabeth J. Bradbury

Elizabeth J. Bradbury

Wolfson Centre for Age-Related Diseases

Publications: 34

Something went wrong. Please try again later.